title: Absence status epilepticus with computed tomographic brain changes following metrizamide myelography.
abstract: Absence status epilepticus following metrizamide myelography was associated with computed tomographic scan evidence of a high concentration of the dye in brain gray matter. We suggest that absence status epilepticus is due to the direct effect of metrizamide on the cortex and that this clinically treatable condition may have escaped diagnosis in previous reports.
authors.affiliation: Department of Neurology, King Khalid University Hospital, Riyadh, Saudi Arabia.
authors.forename: T
authors.initials: T
authors.lastname: Obeid
authors.forename: B
authors.initials: B
authors.lastname: Yaqub
authors.forename: C
authors.initials: C
authors.lastname: Panayiotopoulos
authors.forename: S
authors.initials: S
authors.lastname: al-Jasser
authors.forename: A
authors.initials: A
authors.lastname: Shabaan
authors.forename: N E
authors.initials: NE
authors.lastname: Hawass
mesh_terms: D000328:Adult; D001921:Brain / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000503:physiopathology; D004569:Electroencephalography; D006801:Humans; D008297:Male; D008793:Metrizamide / Q000009:adverse effects* / Q000493:pharmacokinetics; D009192:Myelography / Q000009:adverse effects*; D013226:Status Epilepticus / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000503:physiopathology; D014057:Tomography, X-Ray Computed
chemical_list: D008793:Metrizamide